BeOne Medicines Sees HK$32.786 Billion in Custodied Shares as Shareholder Deposits 130 Million Shares with Citibank

Stock News11-12 08:16

According to the latest data from the Hong Kong Stock Exchange, BeOne Medicines (06160) experienced a position change on November 11, with total custodied market value reaching HK$32.786 billion, accounting for 8.43%.

A shareholder of the company deposited 130 million shares with Citibank, increasing their shareholding ratio by 8.46%.

CLSA released a research report raising its target price for BeOne Medicines from HK$321.7 to HK$336.8, while also raising its target price for the U.S.-listed shares (ONC.US) from US$522.5 to US$561.3, maintaining an "Outperform" rating.

The firm raised its revenue forecasts for the company for 2026 to 2028 by 3.9%, 2.2%, and 1.9% respectively, and its net profit forecasts by 13.3%, 3.5%, and 2.1% respectively.

The company's third-quarter revenue and net profit both exceeded market expectations, primarily driven by strong sales performance of Brukinsa.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment